Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2020

Knightscope Creates AI-equipped Sentinels to Keep America’s Industries and Institutions Safe

Security robot developer Knightscope has created autonomous sentry models that patrol properties and collect data to maintain a heightened level of public safety The company currently markets a K1 stationary machine, K3 indoor machine and K5 outdoor machine that have … Continue reading

Posted in Knightscope, Inc. | Leave a comment

SRAX Inc. (NASDAQ: SRAX) Sells Remaining MD Stake For $8 Million, Focused on Growing SaaS Data Management Investor Platform

SRAX sells remaining MD ownership stake for $8 million MD sale allows SRAX to focus on rapid growth of Sequire platform Sequire unlocks big data investor insights for public companies Sequire revenue grew 29% year-over-year for Q2 2020, user base … Continue reading

Posted in SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) to Release Q3 2020 Financial Results, Host Conference Call

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it will report its unaudited third quarter 2020 financial results before the U.S. market opens on Tuesday, November 24, 2020. … Continue reading

Posted in iClick Interactive Asia Group Ltd. ICLK, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Q2 2021 Financial Results

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today released its unaudited condensed interim consolidated financial statements and management’s discussion and analysis (“MD&A”) for the three and six months ended September 30, 2020 (“Q2 2021”). … Continue reading

Posted in Canopy Rivers Inc. CNPOF, Canopy Rivers Inc. RIV, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Unveil Adaptive Design for Berubicin Phase 2 Clinical Trial in Nov. 12 Webinar

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its plans to issue a video update at 4:30 p.m. ET on … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP, MissionIRNewsBreaks | Leave a comment

Predictive Oncology (NASDAQ: POAI) Subsidiary’s HSC Technology Optimization Solution Offers Unparalleled Results, Benefits

POAI subsidiary Soluble Biotech’s optimization solution shaves time and cost off of traditional options offered by competition Results garnered from company’s HSC optimization are unparalleled in field Soluble Biotech lands first major contract, signifying major company milestone Offering a proprietary … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

Acquisition Strategy Paying Off for Sustainable Green Team, Ltd. (SGTM) Through Increased Profits, International Expansion

National Storm Recovery Inc. acquired Mulch Manufacturing Inc. several months ago to create SGTM SGTM diverts storm waste from landfills to create attractive next-generation products that benefit the environment Mulch Manufacturing recently secured many new contracts that include The Kroger … Continue reading

Posted in Sustainable Green Team Ltd. SGTM | Leave a comment

MissionIRNewsBreaks – CYBIN Inc. Completes Reverse Takeover Transaction

CYBIN (formerly Clarmin Explorations Inc.), a life sciences company initially focused on psychedelic pharmaceutical therapies, on Thursday announced it has completed its previously disclosed reverse takeover of Clarmin Explorations Inc. per the terms of an amalgamation agreement dated June 26, … Continue reading

Posted in Cybin Corp., MissionIRNewsBreaks | Leave a comment

Knightscope, Inc. Is ‘One to Watch’

Knightscope is a leader in the development of autonomous security capabilities and is on target to disrupt the $500 billion security industry The company is presently in the process of raising up to $25 million in additional growth capital as … Continue reading

Posted in Knightscope, Inc. | Leave a comment

VistaGen Therapeutics’ (NASDAQ: VTGN) New Generation Phase 3 Drug Candidate for Social Anxiety Disorder Gains Importance Amid FDA Wariness of Benzodiazepines

VistaGen has three innovative CNS drug candidates which target a wide range of anxiety, depression and neurological disorders PH94B, the Company’s most advanced drug candidate, is entering Phase 3 development for acute, on-demand treatment of social anxiety disorder Company sees … Continue reading

Posted in VistaGen Therapeutics Inc. VTGN | Leave a comment